Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-11

Clinical Trial Update: PCOS Patients' Immune Alterations

View source ↗

Summary

A completed clinical trial evaluated immune alterations in polycystic ovary syndrome patients, with metformin used as part of the study conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Shanghai 10th People's Hospital | Conditions: Polycystic Ovary Syndrom, Metformin | Status: COMPLETED